首页> 外文OA文献 >Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial

【2h】

Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial

机译：米拉贝隆在有或没有接受过抗毒蕈碱治疗的膀胱过动症患者中的疗效：一项欧洲-澳大利亚3期随机试验的事后分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial [J] . Vik Khullar, Javier Cambronero, Javier C Angulo, BMC Urology . 2013,第1期

机译：米拉贝隆在有或没有接受过抗毒蕈碱治疗的膀胱过度活动症患者中的疗效：一项欧洲-澳大利亚3期随机试验的事后分析
2. The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial [J] . Jose E. Batista, Heinz K?lbl, Sender Herschorn, Therapeutic advances in urology. . 2015,第4期

机译：米拉贝隆与索非那新相比因缺乏疗效而对先前过度抗毒蕈碱治疗不满意的膀胱过度活跃患者的疗效和安全性：一项非劣效性，随机，IIIb期临床试验的结果
3. Für Sie gelesen: Efficacy and Tolerability of Mirabegron, a beta3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from aRandomised European-Australian Phase3 Trial. [J] . Baminger H Journal fuer Urologie und Urogynaekologie: Zeitschrift fuer Urologie und Urogynaekologie in Klinik und Praxis . 2014,第3期

机译：FürSie gelesen：膀胱过动症患者中β3-肾上腺素受体激动剂Mirabegron的疗效和耐受性：欧洲-澳大利亚随机3期临床试验的结果。
4. Impact of Complementary Therapies via Mobile Technologies on Icelandic Same Day Surgical Patients' Reports of Anxiety, Pain and Self-Efficacy in Healing: A Randomized Controlled Trial in Process [C] . Margaret M. Hansen MEDINFO . 2013

机译：互补疗法通过移动技术对冰岛同日外科患者的影响焦虑，痛苦和自我疗效愈合中的报告：过程中的随机对照试验
5. Hypotensive resuscitation versus standard fluid resuscitation for the management of trauma patients in hemorrhagic shock: The safety phase of a randomized controlled trial. [D] . Morrison, C. Anne. 2009

机译：低血压复苏与标准液体复苏在失血性休克中对创伤患者的处理：一项随机对照试验的安全性阶段。
6. Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial [O] . Vik Khullar, Javier Cambronero, Javier C Angulo, 2013

机译：米拉贝隆在有或没有接受过抗毒蕈碱治疗的膀胱过动症患者中的疗效：一项欧洲-澳大利亚3期随机试验的事后分析
7. Cardiovascular safety of antimuscarinic add‐on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A post hoc analysis from the Japanese MILAI II study [O] . Takao Katoh, Yasuhiko Igawa, Osamu Yamaguchi, 2019

机译：对患者过度活性膀胱患者的心血管安全性对M拉萨比顿单药治疗的次优应对：日本Milai II研究的后HOC分析

Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial

著录项

相似文献

相关主题

期刊订阅